Search results for: 'navigation diseas standard'
- Related search terms
- Navigation CX in the retail industry 2025-2027
- diseas solution market research methodology greater china
- diseas destructive services market research
- diseas privacy as a service market
- diseas monetization market to real
-
22 Aug 2023  |  North America  |  Market Research
Growth Opportunities for In-vehicle Navigation Services
Megatrends Including Electric and Automated Vehicles to Redefine and Transform In-vehicle Navigation Services, Demanding Ample Consumer Attention
Navigation systems are among the initial in-vehicle innovations added for consumer convenience that have evolved as more technological advancements emerge. With in-vehicle connectivity, use cases for in-vehicle navigation systems have expanded, allowing new opportunities for in-vehicle navigation services. Frost & Sullivan has interviewed thought...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Feb 2016  |  North America  |  Market Research
US Autoimmune Disease Diagnostics Market, Forecast to 2020
Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...
$1,500.00
Special Price $1,125.00 save 25 %
-
20 Jan 2023  |  North America  |  Frost Radar
Frost Radar™: Automotive In-vehicle Navigation, 2022
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
As the automotive industry becomes increasingly reliant on connected and automated technologies, in-vehicle navigation and location-based services are informing much more than direction-impaired drivers. Automakers rely on these systems to ensure vehicle performance as well as passenger and vehicle safety. Today’s in-vehicle navigation features sup...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2019  |  North America  |  Market Research
Global Automotive Navigation System Market, Forecast to 2025
Real-Time Contextual Navigation Services to Catalyse Future Growth
The focus of this study is to strategically analyze the market for automotive navigation systems in North America, South America, Europe, and China. Key market drivers, restraints, and trends are covered, and recent developments in the market are discussed. The study provides a unit shipment forecast analysis of original equipment embedded navigati...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Jun 2022  |  North America  |  Market Research
US Automotive In-vehicle Navigation Growth Opportunities
Augmented Reality, Sensors, Connected Data, and AI Set to Transform Navigation Services for Users and Businesses
The US automotive in-vehicle navigation market is converging. Numerous technological developments, such as cloud computing and AI/ML capabilities, have created numerous new use cases. These opportunities include the integration of augmented reality in head-up display (AR HUD), HD mapping and sensor analysis for ADAS, and personalized services to el...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Dec 2022  |  North America  |  Market Research
PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities
Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem
Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...
$2,450.00
Special Price $1,837.50 save 25 %
-
23 Sep 2016  |  North America  |  Customer Research
Navigating Digital Transformation in Healthcare
This study is part of the Digital Transformation in Vertical Industry series. It is derived from a survey of IT decision makers around the world across multiple industries. It provides insightful information on what drives investment in IT solutions, the IT-related challenges that organizations face today, and most importantly, plans for IT budgets...
$3,000.00
Special Price $2,250.00 save 25 %
-
06 Oct 2021  |  North America  |  Market Research
US Chronic Disease Management Growth Opportunities
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
The prevalence of chronic diseases has continued to rise, and the expenses of managing them or treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behavioral change, several tools and approaches ...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
CLIA Waived Molecular POCT, Coupled with Upcoming Diseases Like Sepsis, Lyme Disease, New Strains of Influenza—H1, H3, and H7, will Drive Growth
Management of infectious diseases remains a critical challenge for public health professionals who face increasing demand to control the spread of existing and novel diseases. To provide appropriate healthcare assistance, it is imperative to diagnose the exact form of infection from an array of complicated symptoms expressed by the host. As the out...
$1,500.00
Special Price $1,125.00 save 25 %
-
28 Sep 2018  |  North America  |  Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00
Special Price $3,712.50 save 25 %